Open transapical approach to transcatheter paravalvular leakage closure: A preliminary experience

Circulation: Cardiovascular Interventions

Volumn 7, Issue 4, 2014, Pages 611-620

  Nijenhuis, Vincent J ^a   Swaans, Martin J ^a   Post, Martijn C ^a   Heijmen, Robin H ^a   De Kroon, Thomas L ^a   Ten Berg, Jurrien M ^a  

^a ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

Heart failure; Heart valve diseases; Heart valve prosthesis; Minimally invasive; Mitral valve insufficiency; Quality of life; Septal occluder device; Surgical procedures

Indexed keywords

AGED; AMPLATZER VASCULAR PLUG; ARTICLE; ATRIAL SEPTAL OCCLUDER; CARDIOVASCULAR MORTALITY; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; EVENT FREE SURVIVAL; FEMALE; HEART FUNCTION TEST; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MALE; NEW YORK HEART ASSOCIATION CLASS; OPEN TRANSAPICAL TRANSCATHETER PARAVALVULAR LEAKAGE CLOSURE; PATIENT SAFETY; POST TREATMENT SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTHESIS FAILURE; PROSTHETIC PARAVALVULAR LEAKAGE; QUALITY OF LIFE; SIX MINUTE WALK TEST; SURVIVAL RATE; TREATMENT OUTCOME; VENTRICULAR SEPTAL OCCLUDER; ADVERSE EFFECTS; CONVALESCENCE; FOLLOW UP; HEART CATHETERIZATION; HEART FAILURE; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; MIDDLE AGED; MORTALITY; PROCEDURES; RISK; SEPTAL OCCLUDER; SURVIVAL; UTILIZATION;

AGED; CARDIAC CATHETERIZATION; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MIDDLE AGED; PROSTHESIS FAILURE; QUALITY OF LIFE; RECOVERY OF FUNCTION; RISK; SEPTAL OCCLUDER DEVICE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84925762667     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.113.001171     Document Type: Article

References (35)

1. Vongpatanasin W, Hillis LD, Lange RA. Prosthetic heart valves. N Engl J Med. 1996;335:407-416.
2. Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, Detaint D, Capps M, Nkomo V, Scott C, Schaff HV, Tajik AJ. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med. 2005;352:875-883.
3. Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, Fontana GP, Dewey TM, Thourani VH, Pichard AD, Fischbein M, Szeto WY, Lim S, Greason KL, Teirstein PS, Malaisrie SC, Douglas PS, Hahn RT, Whisenant B, Zajarias A, Wang D, Akin JJ, Anderson WN, Leon MB; PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366:1686-1695.
4. Echevarria JR, Bernal JM, Rabasa JM, Morales D, Revilla Y, Revuelta JM. Reoperation for bioprosthetic valve dysfunction. A decade of clinical experience. Eur J Cardiothorac Surg. 1991;5:523-526, discussion 527.
5. Jaussaud N, Gariboldi V, Grisoli D, Berbis J, Kerbaul F, Riberi A, Collart F. Risk of reoperation for mitral bioprosthesis dysfunction. J Heart Valve Dis. 2012;21:56-60.
6. Vogt PR, Brunner-LaRocca H, Sidler P, Zund G, Truniger K, Lachat M, Turina J, Turina MI. Reoperative surgery for degenerated aortic bioprostheses: predictors for emergency surgery and reoperative mortality. Eur J Cardiothorac Surg. 2000;17:134-139.
7. Zamorano JL, Badano LP, Bruce C, Chan KL, Goncalves A, Hahn RT, Keane MG, La Canna G, Monaghan MJ, Nihoyannopoulos P, Silvestry FE, Vanoverschelde JL, Gillam LD. EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. J Am Soc Echocardiogr. 2011;24:937-965.
8. Sorajja P, Cabalka AK, Hagler DJ, Rihal CS. Long-term follow-up of percutaneous repair of paravalvular prosthetic regurgitation. J Am Coll Cardiol. 2011;58:2218-2224.
9. Ruiz CE, Jelnin V, Kronzon I, Dudiy Y, Del Valle-Fernandez R, Einhorn BN, Chiam PT, Martinez C, Eiros R, Roubin G, Cohen HA. Clinical outcomes in patients undergoing percutaneous closure of periprosthetic paravalvular leaks. J Am Coll Cardiol. 2011;58:2210-2217.
10. Kappetein AP, Head SJ, Genereux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es GA, Hahn RT, Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rodes-Cabau J, Vranckx P, Webb JG, Windecker S, Serruys PW, Leon MB. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol. 2012;60:1438-1454.
11. Swaans MJ, Post MC, van der Ven HA, Heijmen RH, Budts W, ten Berg JM. Transapical treatment of paravalvular leaks in patients with a logistic EuroSCORE of more than 15%: acute and 3-month outcomes of a "proof of concept" study. Catheter Cardiovasc Interv. 2012;79:741-747.
12. Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, Serebruany V, Valgimigli M, Vranckx P, Taggart D, Sabik JF, Cutlip DE, Krucoff MW, Ohman EM, Steg PG, White H. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation. 2011;123:2736-2747.
13. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A; Acute Kidney Injury Network. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31.
14. Bittner V, Weiner DH, Yusuf S, Rogers WJ, McIntyre KM, Bangdiwala SI, Kronenberg MW, Kostis JB, Kohn RM, Guillotte M. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators. JAMA. 1993;270:1702-1707.
15. Brown SC, Boshoff DE, Rega F, Eyskens B, Budts W, Heidbuchel H, Meyns B, Gewillig M. Transapical left ventricular access for difficult to reach interventional targets in the left heart. Catheter Cardiovasc Interv. 2009;74:137-142.
16. Sorajja P, Cabalka AK, Hagler DJ, Rihal CS. Percutaneous repair of paravalvular prosthetic regurgitation: acute and 30-day outcomes in 115 patients. Circ Cardiovasc Interv. 2011;4:314-321.
17. Goktekin O, Vatankulu MA, Tasal A, Sonmez O, Bael H, Topuz U, Ergelen M, Hijazi ZM. Transcatheter trans-apical closure of paravalvular mitral and aortic leaks using a new device: first in man experience. Catheter Cardiovasc Interv. 2014;83:308-314.
18. Lim DS, Ragosta M, Dent JM. Percutaneous transthoracic ventricular puncture for diagnostic and interventional catheterization. Catheter Cardiovasc Interv. 2008;71:915-918.
19. Lang N, Kozlik-Feldmann R, Dalla Pozza R, Hinterseer M, Sodian R, Abicht J, Kowalski C, Netz H, Reichart B, Schmitz C. Hybrid occlusion of a paravalvular leak with an Amplatzer Septal Occluder after mechanical aortic and mitral valve replacement. J Thorac Cardiovasc Surg. 2010;139:221-222.
20. Larman M, Lasa G, Sanmartin JC, Gaviria K. Transapical technique as an alternative approach to paravalvular leak closure. Rev Esp Cardiol (Engl Ed). 2011;64:80-82.
21. Nietlispach F, Johnson M, Moss RR, Wijesinghe N, Gurvitch R, Tay EL, Thompson C, Webb JG. Transcatheter closure of paravalvular defects using a purpose-specific occluder. JACC Cardiovasc Interv. 2010;3:759-765.
22. Martinez CA, Rosen R, Cohen H, Ruiz CE. A novel method for closing the percutaneous transapical access tract using coils and gelatin matrix. J Invasive Cardiol. 2010;22:E107-E109.
23. Hammerstingl C, Nickenig G, Endlich M, Mellert F, Schiller W. Treatment of a severely degenerated mitral valve bioprosthesis with simultaneous transapical paravalvular leak closure and valve-in-valve implantation. Eur Heart J. 2012;33:1976
24. Smith CR, Stamou SC, Merhi WM, Hooker RL. Repair of paravalvular prosthetic mitral valve leaks with septal occluder devices in severely high-risk patients: a word of caution. Interact Cardiovasc Thorac Surg. 2012;15:544-546.
25. Guler A, Tavlasoglu M, Kadan M, Barcin C. Transapical closure of mitral paravalvular leakage. Eur J Cardiothorac Surg. 2013;43:861-863.
26. Thourani VH, Smith CM, Guyton RA, Block P, Liff D, Willis P, Lerakis S, Arepalli CD, Howell S, Boulton BJ, Stewart J, Babaliaros V. Repair of prosthetic mitral valve paravalvular leak using an off-pump transapical approach. Ann Thorac Surg. 2012;94:275-278.
27. Nietlispach F, Eckstein F, Seeberger M, Osswald S, Kaufmann BA, Reuthebuch O. Closure of apical access site after transapical, transcatheter paravalvular leak closure. Can J Cardiol. 2012;28:516.e5-516.e7.
28. Smolka G, Pysz P, Jasinski M, Goco R, Domaradzki W, Hudziak D, Deja M, Ochaa A, Gasior Z. Transapical closure of mitral paravalvular leaks with use of Amplatzer vascular plug III. J Invasive Cardiol. 2013;25:497-501.
29. Jelnin V, Dudiy Y, Einhorn BN, Kronzon I, Cohen HA, Ruiz CE. Clinical experience with percutaneous left ventricular transapical access for interventions in structural heart defects a safe access and secure exit. JACC Cardiovasc Interv. 2011;4:868-874.
30. Mookadam F, Raslan SF, Jiamsripong P, Jalal U, Murad MH. Percutaneous closure of mitral paravalvular leaks: a systematic review and meta-analysis. J Heart Valve Dis. 2012;21:208-217.
31. Sorajja P, Cabalka AK, Hagler DJ, Rihal CS. The learning curve in percutaneous repair of paravalvular prosthetic regurgitation: an analysis of 200 cases. JACC Cardiovasc Interv. 2014;7:521-529.
32. Akins CW, Bitondo JM, Hilgenberg AD, Vlahakes GJ, Madsen JC, MacGillivray TE. Early and late results of the surgical correction of cardiac prosthetic paravalvular leaks. J Heart Valve Dis. 2005;14:792-729, discussion 799-800.
33. Genoni M, Franzen D, Vogt P, Seifert B, Jenni R, Kunzli A, Niederhauser U, Turina M. Paravalvular leakage after mitral valve replacement: improved long-term survival with aggressive surgery? Eur J Cardiothorac Surg. 2000;17:14-19.
34. Genoni M, Franzen D, Tavakoli R, Seiffert B, Graves K, Jenni R, Turina M. Does the morphology of mitral paravalvular leaks influence symptoms and hemolysis? J Heart Valve Dis. 2001;10:426-430.
35. Ghofrani HA, Galie N, Grimminger F, Grunig E, Humbert M, Jing ZC, Keogh AM, Langleben D, Kilama MO, Fritsch A, Neuser D, Rubin LJ; PATENT-1 Study Group. Riociguat for the treatment of pulmonary arterial hypertension. N Engl J Med. 2013;369:330-340.